Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study

Fig. 4

Concentrated number of endothelial and hematopoietic progenitor cell phenotypes in BMMC. a–d The frequency of cell subpopulations was obtained after labeling of total bone marrow-derived mononuclear cells (BMMC) (1 × 106 cells) separately with antibodies (set 1 CD133/CD34/KDR or set 2 CD34/KDR/CD45) and analysis by flow cytometry. Phenotypes CD34+/KDR+ (a), CD34+/KDR+/CD133+ (b), CD34/CD45dim (c) and CD34+/KDR+/CD45dim (d) were concentrated in the implanted BMMC of SCD patients. e Concentration factor calculated by the quotient of the specified phenotype number in BMMC/BMA. The high standard deviation indicates the high variability of cell phenotypes within the SCD bone marrow. Data are represented as individuals values. Horizontal bars indicate mean value. *P < 0.05, **P < 0.01, ***P < 0.005, ****P < 0.001. BMA bone marrow aspirate

Back to article page